Kruse; Lawrence I.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Kruse; Lawrence I..The latest application filed is for "small organic molecule regulators of cell proliferation".

Company Profile

0.17.7

Kruse; Lawrence I. - Claremont NH
Kruse; Lawrence I. - Haddonfield NJ
Kruse; Lawrence I. - Malvern PA
Kruse; Lawrence I. - Tewin GB2
Kruse; Lawrence I. - Philadelphia PA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Small Organic Molecule Regulators Of Cell Proliferation App 20120245184 - Brunton; Shirley Ann ; et al.	2012-09-27
Small organic molecule regulators of cell proliferation Grant 8,273,747 - Brunton , et al. September 25, 2	2012-09-25
Small organic molecule regulators of cell proliferation App 20080194637 - Brunton; Shirley Ann ; et al.	2008-08-14
Small organic molecule regulators of cell proliferation App 20080193423 - Brunton; Shirley Ann ; et al.	2008-08-14
Small organic molecule regulators of cell proliferation App 20080182859 - Brunton; Shirley Ann ; et al.	2008-07-31
Kappa agonist compounds and pharmaceutical formulations thereof Grant 7,294,647 - Kruse , et al. November 13, 2	2007-11-13
Kappa agonist compounds, pharmaceutical formulations and method of prevention and treatment of pruritus therewith Grant 6,960,612 - Kruse , et al. November 1, 2	2005-11-01
Kappa agonist compounds, pharmaceutical formulations and method of prevention and treatment of pruritus therewith App 20040220112 - Kruse, Lawrence I. ; et al.	2004-11-04
Kappa agonist compounds and pharmaceutical formulations thereof App 20030236248 - Kruse, Lawrence I. ; et al.	2003-12-25
Kappa agonist compounds, pharmaceutical formulations and method of prevention and treatment of pruritus therewith App 20020042399 - Kruse, Lawrence I. ; et al.	2002-04-11
Kappa agonist compounds, pharmaceutical formulations and method of prevention and treatment of pruritus therewith Grant 6,180,623 - Kruse , et al. January 30, 2	2001-01-30
Kappa agonist compounds, pharmaceutical formulations and method of prevention and treatment of pruritus therewith Grant 6,028,063 - Kruse , et al. February 22, 2	2000-02-22
Kappa agonist compounds, pharmaceutical formulations and method of prevention and treatment of pruritus therewith Grant 5,981,513 - Kruse , et al. November 9, 1	1999-11-09
Kappa agonist compounds pharmaceutical formulations and method of prevention and treatment of pruritus therewith Grant 5,763,445 - Kruse , et al. June 9, 1	1998-06-09
Kappa agonist compounds and pharmaceutical formulations thereof Grant 5,744,458 - Kruse , et al. April 28, 1	1998-04-28
Kappa agonist compounds and pharmaceutical formulations thereof Grant 5,688,955 - Kruse , et al. November 18, 1	1997-11-18
Kappa agonist compounds and pharmaceutical formulations thereof Grant 5,646,151 - Kruse , et al. July 8, 1	1997-07-08
2-(substituted phenyl)-4-oxo-quinazolines Grant 5,147,875 - Coates , et al. September 15, 1	1992-09-15
Dopamine-.beta.-hydroxylase inhibitors Grant 4,935,438 - Kruse , et al. June 19, 1	1990-06-19
2-mercaproimidazole dopamine-.beta.-hydroxylase inhibitors Grant 4,798,843 - Kruse January 17, 1	1989-01-17
Irreversible dopamine-.beta.-hydroxylase inhibitors Grant 4,760,089 - Chambers , et al. July 26, 1	1988-07-26
1-Benzyl-2-aminomethyl imidazole derivatives Grant 4,532,331 - Frazee , et al. July 30, 1	1985-07-30
Semicarbazide intermediates for preparing 4-substituted indoles Grant 4,454,337 - Kruse June 12, 1	1984-06-12
Processes for preparing 4-substituted indoles Grant 4,394,514 - Kruse July 19, 1	1983-07-19

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.